Main > A1. CORP. INDEX. R-Rm > ReShape Lifesciences Inc./P C2

This data is not available for free

ReShape Lifesciences Inc./P C2's subsections
2011. 06.17. Results Phase I
2011. 10.04. Pres. & CEO
2014. 11.06. Obesity
2015. 07.28. Obesity
2018. 06.05. Patent
2021. 01.20. Obalon Therapeutics
Web-Site

ReShape Lifesciences Inc./P C2's products
This section has no products